Distribution of Clostridioides difficile ribotypes and sequence types across humans, animals and food in 13 European countries

Emerg Microbes Infect. 2024 Dec;13(1):2427804. doi: 10.1080/22221751.2024.2427804. Epub 2024 Nov 27.

Abstract

Clostridioides difficile is a One Health pathogen found in humans, animals, and the environment, with food representing a potential transmission route. One Health studies are often limited to a single country or selected reservoirs and ribotypes. This study provides a varied and accessible collection of C. difficile isolates and sequencing data derived from human, animal, and food sources across 13 European countries. A total of 441 strains (human hospital- and community-associated cases n = 280, animal n = 96, food n = 65) were analysed by ribotyping, toxinotyping and whole-genome sequencing (WGS). We detected 83 sequence types (STs), with ST11 (n = 80 isolates) and ST1 (n = 54 isolates) being the most represented. Several STs included strains originating from all source combinations. Further genomic analysis confirmed close genetic relatedness in some of the STs. Additionally, the genomic analysis identified 10 strains from cryptic clades (C-I to C-III) and 4 of them were mono-toxigenic possessing only a variant form of tcdA gene. Amongst 106 ribotypes, 10 were shared between all 3 sources and 68 were source-specific. Some ribotypes were only found at the intersection of human and food source (RT023, RT027), or between human and animal source (RT009, RT045, RT046). C. difficile ribotypes and STs in Europe were diverse. In this collection, some ribotypes showed potential association with food or animal transmission routes. C. difficile strains from divergent clades CI-III, currently emerging in the human population, were rare and mostly food-associated.Trial registration: ClinicalTrials.gov identifier: NCT03503474.

Keywords: One Health; animals; community-associated; cryptic clades; epidemiology; food; hospital-associated; transmission.

MeSH terms

  • Adult
  • Aged
  • Animals
  • Clostridioides difficile* / classification
  • Clostridioides difficile* / genetics
  • Clostridioides difficile* / isolation & purification
  • Clostridium Infections* / epidemiology
  • Clostridium Infections* / microbiology
  • Clostridium Infections* / transmission
  • Europe / epidemiology
  • Female
  • Food Microbiology*
  • Genome, Bacterial
  • Humans
  • Male
  • Middle Aged
  • Phylogeny
  • Ribotyping*
  • Whole Genome Sequencing*

Associated data

  • ClinicalTrials.gov/NCT03503474

Grants and funding

The study was supported by Innovative Medicines Initiative 2 Joint Undertaking under grant agreement n° 777362 (COMBACTE – CDI) resources which are composed of financial contributions from the European Union’s Horizon 2020 research and innovation programme, and EFPIA. The funder contributed financially to the study design but did not contribute to data collection, analysis, interpretation, preparation of the manuscript or the decision to publish.